Cash Flow Statement
Growth Metrics

Biolife Solutions (BLFS) Short-Term Debt repayments (2021)

Biolife Solutions (BLFS) reported Short-Term Debt repayments of $2.9 million for Q4 2021, down 81.91% on a QoQ basis from $15.9 million in Q3 2021.

Biolife Solutions (BLFS) has 1 years of Short-Term Debt repayments data on file, last reported at $2.9 million in Q4 2021.

  • Quarterly Short-Term Debt repayments changed N/A year-over-year to $2.9 million in Q4 2021, while the trailing twelve-month figure through Dec 2022 was $18.8 million (changed 0.0% YoY) and the FY2021 annual result came in at $31.5 million, changed N/A from the prior year.
  • Short-Term Debt repayments slipped to $2.9 million in Q4 2021 per BLFS's latest filing, from $15.9 million in the prior quarter.
  • Across five years, Short-Term Debt repayments topped out at $15.9 million in Q3 2021 and bottomed at $2.9 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt repayments (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -
10 Biolife Solutions 1.20 Bn 1.12 Bn 17.50 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2021 2.88 Mn
Dec 31, 2021 2.88 Mn
Sep 30, 2021 15.92 Mn
Sep 30, 2021 15.92 Mn